FDA Guides Biologics Makers On Safety Evaluations
The U.S. Food and Drug Administration on Thursday finalized guidance on how biologics makers can identify and reduce safety risks, outlining numerous scientific considerations that may emerge depending on patient population...To view the full article, register now.
Already a subscriber? Click here to view full article